Li-Fraumeni Syndrome
Li-Fraumeni Syndrome: Genetics and Public Health - June 11, 2015
Surveillance recommendations for patients with germline TP53 mutations.
Ballinger ML et al. Curr Opin Oncol 2015 Jul (4) 332-7
Ballinger ML et al. Curr Opin Oncol 2015 Jul (4) 332-7
Revisiting Li-Fraumeni syndrome from TP53 mutation carriers.
Bougeard G et al. J. Clin. Oncol. 2015 May 26.
Bougeard G et al. J. Clin. Oncol. 2015 May 26.
Committee opinion no. 634: hereditary cancer syndromes and risk assessment.
Obstet Gynecol 2015 Jun (6) 1538-43
Obstet Gynecol 2015 Jun (6) 1538-43
A beleaguered family — 12 in 4 generations diagnosed with cancer, so far, by Doug Robinson, Deseret News, Dec 27, 2014
by Doug Robinson, Deseret News, Dec 27, 2014What is Li-Fraumeni syndrome? By Katherine Schneider, GeneReviews, (2013)
By Katherine Schneider, GeneReviews, (2013)Li-Fraumeni syndrome: NIH Genetics Home Reference Information
NIH Genetics Home Reference InformationLi-Fraumeni syndrome: cancer risk assessment and clinical management.
McBride KA, et al. Nat Rev Clin Oncol. 2014 May;11(5):260-71
McBride KA, et al. Nat Rev Clin Oncol. 2014 May;11(5):260-71
p53 and hereditary cancer
Merino D, et al. Subcell Biochem. 2014;85:1-16.
Merino D, et al. Subcell Biochem. 2014;85:1-16.
Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li-Fraumeni cancer predisposition syndrome.
Ariffin H, et al. Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15497-501
Ariffin H, et al. Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15497-501
.png)
No hay comentarios:
Publicar un comentario